These results suggest that the proteolytic cleavage of Lf in patients with CF can contribute to B. cenocepacia and P. aeruginosa-associated lung damage, and that infection-associated lung damage can be improved by the exogenous therapeutic administration of Lf, due to its potent immunomodulatory properties. This evidence concerns the gene LTF and infection.